Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Night-time Dexmedetomidine-esketamine Infusion on Sleep Quality of Patients With Mechanical Ventilation or High-flow Nasal Cannula Oxygen Therapy in ICU: a Randomized Controlled Trial

NCT05718024 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05718024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05718024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Night-time Dexmedetomidine-esketamine Infusion on Sleep Quality of Patients With Mechanical Ventilation or High-flow Nasal Cannula Oxygen Therapy in ICU: a Randomized Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 1, 2023
Completion date
May 23, 2025
Enrollment
174 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, esketamine, intensive care unit, mechanical ventilation, sleep quality